Gainers
- Biodexa Pharmaceuticals BDRX stock rose 183.2% to $14.19 during Wednesday's pre-market session. The market value of their outstanding shares is at $206.0 million.
- Carmell CTCX stock rose 38.87% to $0.48. The company's market cap stands at $10.0 million.
- Tempest Therapeutics TPST shares increased by 24.82% to $1.46. The company's market cap stands at $36.8 million.
- NovoCure NVCR stock increased by 22.27% to $21.74. The market value of their outstanding shares is at $2.3 billion.
- NeuroBo Pharmaceuticals NRBO shares increased by 17.39% to $2.97. The market value of their outstanding shares is at $25.2 million.
- Windtree Therapeutics WINT shares rose 16.33% to $0.77. The company's market cap stands at $2.8 million.
Losers
- Novavax NVAX stock declined by 19.5% to $10.14 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.6 billion.
- Assembly Biosciences ASMB shares decreased by 18.69% to $15.06. The market value of their outstanding shares is at $95.5 million.
- Dogwood Therapeutics DWTX shares declined by 13.67% to $3.16. The market value of their outstanding shares is at $4.2 million.
- INVO Bioscience INVO shares fell 11.76% to $0.9. The market value of their outstanding shares is at $3.5 million.
- NewGenIvf Group NIVF shares fell 10.21% to $1.76. The market value of their outstanding shares is at $17.8 million.
- ABVC BioPharma ABVC shares declined by 8.86% to $0.54. The company's market cap stands at $6.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ASMBAssembly Biosciences Inc
$15.503.89%
BDRXBiodexa Pharmaceuticals PLC
$4.066.28%
CTCXCarmell Corp
$0.260115.3%
DWTXDogwood Therapeutics Inc
$2.802.94%
NIVFNewGenIvf Group Ltd
$0.3410-2.57%
NVAXNovavax Inc
$8.50-1.62%
NVCRNovoCure Ltd
$30.961.54%
TPSTTempest Therapeutics Inc
$0.85731.26%
WINTWindtree Therapeutics Inc
$0.3100-4.62%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in